What's new

Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 29/07/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 29/07/2018, Revision: 12, Status: Authorised

Feb 12, 2025 - 09:18
 0
Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 29/07/2018, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 29/07/2018, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

GSK plans to move vaccine R&D center from Rockville, Md. to the Boston area

Next Article

High-Efficiency Moisture Energy Harvesting at -30 oC via Hybrid Solute Engineering

Related Posts

Methylphenidate, prolonged-release tablet 18 mg, 27 mg,...

Feb 10, 2025  0

Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0

EMEA-003499-PIP01-23

EMEA-003499-PIP01-23

Feb 13, 2025  0